Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-29 Purchase | 2022-07-01 4:05 pm | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 20,000 | $1.71 | $34,200 | 27,754 (Indirect Direct) | View |
| 2022-03-25 Purchase | 2022-03-28 08:00 am | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 100,000 | $0.245 | $24,500 | 248,024 (Indirect Direct) | View |
| 2021-09-28 Purchase | 2021-09-28 5:04 pm | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 12,000 | $0.61 | $7,320 | 148,024 (Indirect Direct) | View |
| 2021-05-25 Purchase | 2021-05-26 09:07 am | Tonix Pharmaceuticals Holding Corp. | TNXP | Goodman Daniel Wintner Director | 5,000 | $1.12 | $5,600 | 5,001 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-27 Option Award(A) | 2024-03-06 5:01 pm | 2025-02-27 2034-02-27 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 3,448,911 | $0 | 3,448,911 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 5:08 pm | 2025-02-27 2034-02-27 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 3,448,911 | $0 | 3,448,911 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 5:07 pm | 2025-02-27 2034-02-27 | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 564,000 | $0 | 564,000 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 5:06 pm | 2025-02-27 2034-02-27 | Tonix Pharmaceuticals Holding Corp. | TNXP | MORRIS JESSICA EDGAR Chief Operating Officer | 634,000 | $0 | 634,000 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 5:05 pm | 2025-02-27 2034-02-27 | Tonix Pharmaceuticals Holding Corp. | TNXP | SULLIVAN GREGORY M Chief Medical Officer | 716,000 | $0 | 716,000 (Direct) | View |
| 2023-05-08 Option Award | 2023-05-10 5:15 pm | 2024-05-08 2033-05-08 | Tonix Pharmaceuticals Holding Corp. | TNXP | BAGGER RICHARD H Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-05-08 Option Award | 2023-05-10 5:14 pm | 2024-05-08 2033-05-08 | Tonix Pharmaceuticals Holding Corp. | TNXP | Bell Margaret Smith Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-05-08 Option Award | 2023-05-10 5:13 pm | 2024-05-08 2033-05-08 | Tonix Pharmaceuticals Holding Corp. | TNXP | GRANGE DAVID L Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-05-08 Option Award | 2023-05-10 5:11 pm | 2024-05-08 2033-05-08 | Tonix Pharmaceuticals Holding Corp. | TNXP | OLUKOTUN ADEOYE Y Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-05-08 Option Award | 2023-05-10 5:09 pm | 2024-05-08 2033-05-08 | Tonix Pharmaceuticals Holding Corp. | TNXP | Stillwell Richard Newcomb Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-05-08 Option Award | 2023-05-10 5:08 pm | 2024-05-08 2033-05-08 | Tonix Pharmaceuticals Holding Corp. | TNXP | Taylor Carolyn E. Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-05-08 Option Award | 2023-05-10 5:01 pm | 2024-05-08 2033-05-08 | Tonix Pharmaceuticals Holding Corp. | TNXP | Treco James Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 7:43 pm | N/A 2033-03-15 | Tonix Pharmaceuticals Holding Corp. | TNXP | Stillwell Richard Newcomb Director | 83,000 | $0 | 83,000 (Direct) | View |
Ownership | 2023-03-16 7:42 pm | N/A 2023-03-15 | Tonix Pharmaceuticals Holding Corp. | TNXP | Stillwell Richard Newcomb Director | 0 | $0 | 83,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 6:38 pm | 2024-02-23 2033-02-23 | Tonix Pharmaceuticals Holding Corp. | TNXP | SULLIVAN GREGORY M Chief Medical Officer | 440,000 | $0 | 440,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 6:37 pm | 2024-02-23 2033-02-23 | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 6:36 pm | 2024-02-23 2033-02-23 | Tonix Pharmaceuticals Holding Corp. | TNXP | MORRIS JESSICA EDGAR Chief Operating Officer | 415,000 | $0 | 415,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 6:34 pm | 2024-02-23 2033-02-23 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 1,400,000 | $0 | 1,400,000 (Direct) | View |
| 2022-05-09 Option Award | 2022-05-11 5:49 pm | 2023-05-09 2032-05-09 | Tonix Pharmaceuticals Holding Corp. | TNXP | Taylor Carolyn E. Director | 2,131,500 | $0 | 2,131,500 (Direct) | View |
| 2022-05-09 Option Award | 2022-05-11 5:46 pm | 2023-05-09 2032-05-09 | Tonix Pharmaceuticals Holding Corp. | TNXP | BAGGER RICHARD H Director | 2,131,500 | $0 | 2,131,500 (Direct) | View |
| 2022-05-09 Option Award | 2022-05-11 5:44 pm | 2023-05-09 2032-05-09 | Tonix Pharmaceuticals Holding Corp. | TNXP | Bell Margaret Smith Director | 2,131,500 | $0 | 2,131,500 (Direct) | View |
| 2022-05-09 Option Award | 2022-05-11 5:42 pm | 2023-05-09 2032-05-09 | Tonix Pharmaceuticals Holding Corp. | TNXP | GRANGE DAVID L Director | 2,131,500 | $0 | 2,131,500 (Direct) | View |
| 2022-05-09 Option Award | 2022-05-11 5:40 pm | 2023-05-09 2032-05-09 | Tonix Pharmaceuticals Holding Corp. | TNXP | OLUKOTUN ADEOYE Y Director | 2,131,500 | $0 | 2,131,500 (Direct) | View |
| 2022-05-09 Option Award | 2022-05-11 5:38 pm | 2023-05-09 2032-05-09 | Tonix Pharmaceuticals Holding Corp. | TNXP | Treco James Director | 2,131,500 | $0 | 2,131,500 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:19 pm | 2023-02-15 2032-02-15 | Tonix Pharmaceuticals Holding Corp. | TNXP | SULLIVAN GREGORY M Chief Medical Officer | 5,000,000 | $0 | 5,000,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:19 pm | 2023-02-15 2032-02-15 | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 3,600,000 | $0 | 3,600,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:18 pm | 2023-02-15 2032-02-15 | Tonix Pharmaceuticals Holding Corp. | TNXP | MORRIS JESSICA EDGAR Chief Operating Officer | 4,400,000 | $0 | 4,400,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:17 pm | 2023-02-15 2032-02-15 | Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer | 20,000,000 | $0 | 20,000,000 (Direct) | View |
| 2021-06-30 Ownership | 2022-02-11 5:18 pm | N/A N/A | Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer | 18,248 | $0.58 | 19,645 (Direct) | View |
| 2021-06-30 Ownership | 2022-02-11 5:17 pm | N/A N/A | Tonix Pharmaceuticals Holding Corp. | TNXP | SULLIVAN GREGORY M Chief Medical Officer | 36,496 | $0.58 | 99,223 (Direct) | View |
| 2021-07-16 Option Award | 2021-07-27 9:46 pm | N/A 2031-07-16 | Tonix Pharmaceuticals Holding Corp. | TNXP | Taylor Carolyn E. Director | 237,437 | $0 | 237,437 (Direct) | View |
Ownership | 2021-07-27 9:45 pm | 2021-07-16 2031-07-16 | Tonix Pharmaceuticals Holding Corp. | TNXP | Taylor Carolyn E. Director | 0 | $0 | 237,437 (Direct) | View |
| 2021-05-10 Option Award | 2021-05-12 4:45 pm | 2022-05-10 2031-05-10 | Tonix Pharmaceuticals Holding Corp. | TNXP | Treco James Director | 270,882 | $0 | 270,882 (Direct) | View |
| 2021-05-10 Option Award | 2021-05-12 4:44 pm | 2022-05-10 2031-05-10 | Tonix Pharmaceuticals Holding Corp. | TNXP | OLUKOTUN ADEOYE Y Director | 270,882 | $0 | 270,882 (Direct) | View |
| 2021-05-10 Option Award | 2021-05-12 4:43 pm | 2022-05-10 2031-05-10 | Tonix Pharmaceuticals Holding Corp. | TNXP | GRANGE DAVID L Director | 270,882 | $0 | 270,882 (Direct) | View |
| 2021-05-10 Option Award | 2021-05-12 4:43 pm | 2022-05-10 2031-05-10 | Tonix Pharmaceuticals Holding Corp. | TNXP | Goodman Daniel Wintner Director | 270,882 | $0 | 270,882 (Direct) | View |